A Retrospective Comparison of Trastuzumab Plus Cisplatin and Trastuzumab Plus Capecitabine in Elderly HER2-Positive Advanced Gastric Cancer Patients
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference26 articles.
1. Efficacy and safety of docetaxel or epirubicin, combined with cisplatin and fluorouracil (DCF and ECF), regimens as first line chemotherapy for advanced gastric cancer: a Retrospective Analysis from Turkey.;Teker;Asian Pac J Cancer Prev,2014
2. Biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer: a randomised phase III trial (TCOG GI-0801BIRIP trial).;Higuchi;Eur J Cancer,2014
3. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.;Van Cutsem;J Clin Oncol,2006
4. Phase II study of S-1 monotherapy in patients over 75 years of age with advanced gastric cancer (OGSG0404).;Imamura;J Chemother,2014
5. S-1-based therapy versus S-1 monotherapy in advanced gastric cancer: a meta-analysis.;Wu;Tumour Biol,2014
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Chemotherapeutic Protocols for the Treatment of Gastrointestinal Tract Cancer;Chemotherapy Protocols and Infusion Sequence;2022
2. Targeted agents in older patients with gastrointestinal cancers – An overview;Journal of Geriatric Oncology;2021-11
3. Recent Advances in Systemic Treatments for HER-2 Positive Advanced Gastric Cancer;OncoTargets and Therapy;2021-07
4. Preoperative neoadjuvant chemotherapy on surgical condition and oncogene expression in advanced gastric cancer;Pakistan Journal of Medical Sciences;2020-03-04
5. Review of survival, safety, and clinical outcomes in HER2+ metastatic gastric cancer following the administration of trastuzumabPost-Trastuzumab Gastric Cancer;Cancer Treatment and Research Communications;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3